Lucas Harrington
@CRISPR_LuCas
Cofounder/President Tx @MammothBiosci Cofounder/Partner @SciFounders PhD from @Doudna_lab
Partnerships have been crucial to Mammoth's success, delivering $200M+ in upfront payments. I wrote up the guide I wish someone had given me when I started out. Hope this helps others close the right deal! 🧵 and link:
Super exciting! Nudge is one of the few neuro techs I've seen that could actually impact everyday people in the near future
Excited to share details of what we are working on @nudge for the first time today. Our mission is to improve everyday life by developing the best technologies for interfacing with the brain.
Over 700 signups for our workshop on how to secure biotech partnerships with @CRISPR_LuCas. Still time to register! lu.ma/89bnm9jk
In the US, embryo editing is barely studied, making a CRISPR baby is prohibited, and there's no startups on the scene. Yet...gene-edit tech continues to advance. Now, billionaire Brian Armstrong says he's ready to fund the defining U.S. embryo-editing company. 👇
For all you gene editing scientists out there, I highly encourage you to join this conversation. We've buried our head in the sand for too long on heritable editing, paving the way for reckless individuals to pave their own path
If you’re a gene editing scientist or comp bio/ML engineer interested in the topic of embryo editing, I’m hosting a dinner in the bay area soon with a few folks. I think the time is right for the defining company in the US to be built in this area, approaching it in a…
5.20.25 – @CRISPR_LuCas on to talk about the first truly personalized CRISPR therapy: • How a six-month sprint led to a custom treatment that may have saved a baby’s life • The future of in vivo editing, and why the brain is the next frontier
The crummiest part of venture capital is having to tell people no. We at @SciFounders often need to make tough decisions. I went back to our notes on the last ~500 startups we met and could boil down our feedback to 7 main factors that I think are critical.
I would pay $100/mo for an email client with good LLM integration using other relevant conversations as context Embarrassing gmail hasn't done this well with Gemini
This is a terrifying trend for American innovation and commercial leadership in biotech. >1/3 of scientific literature is life sciences. We should be doing everything possible to turn this around.
US universities were the best in the world when they sourced the best in the world. But now they don’t do that, because of DEI. And soon they can’t do that, because of visas. So, they just become regional players. And China takes the #1 spot.
